LB-102
Live / Applied — Second extension granted (statement of use) (as of 13 Jan 2026)
What this means for you
Not registered yet, but its 22 Apr 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98512410
- Mark type
- Stylized text
- Filed
- 22 Apr 2024
- Published for opposition
- 03 Dec 2024
- Attorney of record
- Winfield B. Martin
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of schizophrenia
Owner
- LB Pharmaceuticals Inc., New York, NY, US
- LB Pharmaceuticals Inc., New York, NY, US
Prosecution history
- 14 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Jan 2026 — SOU EXTENSION 2 GRANTED
- 13 Jan 2026 — SOU EXTENSION 2 FILED
- 13 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 12 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Jul 2025 — SOU EXTENSION 1 GRANTED
- 11 Jul 2025 — SOU EXTENSION 1 FILED
- 11 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 13 May 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 13 May 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 13 May 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 14 Jan 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Dec 2024 — PUBLISHED FOR OPPOSITION
- 27 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED